Gottlieb, biosimilars companies and consultants reject price control proposal

Gottlieb, biosimilars companies and consultants reject price control proposal

Source: 
BioCentury
snippet: 

Former FDA Commissioner Scott Gottlieb, biosimilars manufacturers and industry consultants pushed back Monday against a proposal to scrap the U.S. biosimilars pathway and instead impose price controls on off-patent biologics.